Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial (Q87702640)
Jump to navigation
Jump to search
scientific article published on 14 April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial |
scientific article published on 14 April 2014 |
Statements
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial (English)
Claudine Isaacs
Ruth O'Regan
Norikazu Masuda
Mustafa Ozguroglu
Binghe Xu
Guy Jerusalem
Sharon Wilks
Zsuzsanna Papai
Istvan Lang
Anne Armstrong
Guillermo Lerzo
Michelle White
Kunwei Shen
Jennifer Litton
David Chen
Yufen Zhang
Shyanne Ali